Furthermore, advanced dual-targeting systems, such as GOx@FeNPs, leverage photothermal therapy (PTT) and ferroptosis synergy to boost CRC cell immunogenicity, enhancing dendritic cell (DC) maturation and CD8+ T-cell activation. This evidence concerns the gene CD8A and colorectal carcinoma.